Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rebus Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rebus Holdings Inc market cap is $32.00.
What is the 52-week high for Rebus Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rebus Holdings Inc 52 week high is $0.0001 as of May 03, 2026.
What was Rebus Holdings Inc stock price yesterday?
Rebus Holdings Inc stock price yesterday was $0.0001.